The tweet was deleted by the author.
But we saved everything 🙂.
Patrick Soon-Shiong announces new cancer trials at cssifm
Healthcare innovator Patrick Soon-Shiong has expanded access to clinical trials for specific cancer types at the Cancer Support SAIFM (cssifm).
These trials are targeted at patients with non-small cell lung cancer who have failed chemotherapy and checkpoint inhibitors, as well as those suffering from glioblastoma that was not successfully treated by surgery, radiation, and temozolomide. The initiative signifies a significant step in providing new treatment avenues for patients facing limited options.
Patrick Soon-Shiong, known for his pioneering work in medicine and health technology, emphasizes the importance of expanding treatment opportunities. He indicates that the trials will primarily target advanced stages of these cancers, offering hope for those in critical need of experimental therapies.
The expansion of clinical trials for challenging cancer cases marks another milestone in Patrick Soon-Shiong’s dynamic approach to medical innovation. This progress aligns with his broader commitment to advancing experimental therapies, as seen in his prior initiative to launch the Bioshield trial targeting long Covid. Beyond the clinical sphere, Soon-Shiong’s influence extends into transformative health technology, reflecting strategic moves such as the integration of NantStudios in next-generation virtual production. Together, these developments underscore his far-reaching efforts to redefine both patient care and the health technology landscape.
This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Subscribe to TU news
Did you like the article?
Latest Patrick Soon-Shiong News
Weekly Top Bonuses
Top News
Top 5 companies for you
United States
-
Afghanistan
-
Albania
-
Algeria
-
Angola
-
Argentina
-
Armenia
-
Australia
-
Austria
-
Azerbaijan
-
Bahamas
-
Bahrain
-
Bangladesh
-
Belarus
-
Belgium
-
Bolivia
-
Botswana
-
Brazil
-
Brunei
-
Bulgaria
-
Cambodia
-
Cameroon
-
Canada
-
Chile
-
China
-
Colombia
-
Congo
-
Costa Rica
-
Cote d'Ivoire
-
Croatia
-
Cuba
-
Cyprus
-
Czechia
-
DR Congo
-
Denmark
-
Dominican Republic
-
Ecuador
-
Egypt
-
El Salvador
-
Estonia
-
Eswatini
-
Ethiopia
-
Finland
-
France
-
Georgia
-
Germany
-
Ghana
-
Greece
-
Haiti
-
Hong Kong
-
Hungary
-
India
-
Indonesia
-
Iran, Islamic republic
-
Iraq
-
Ireland
-
Israel
-
Italy
-
Jamaica
-
Japan
-
Jordan
-
Kazakhstan
-
Kenya
-
Korea
-
Kuwait
-
Kyrgyzstan
-
Laos
-
Latvia
-
Lebanon
-
Lesotho
-
Libya
-
Lithuania
-
Luxembourg
-
Madagascar
-
Malaysia
-
Malta
-
Mauritius
-
Mexico
-
Moldova
-
Mongolia
-
Montenegro
-
Morocco
-
Mozambique
-
Myanmar
-
Namibia
-
Nepal
-
Netherlands
-
New Zealand
-
Nigeria
-
North Macedonia
-
Norway
-
Oman
-
Pakistan
-
Palestine
-
Panama
-
Papua New Guinea
-
Paraguay
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Puerto Rico
-
Qatar
-
Reunion
-
Romania
-
Rwanda
-
Saudi Arabia
-
Serbia
-
Singapore
-
Slovakia
-
Slovenia
-
Somalia
-
South Africa
-
Spain
-
Sri Lanka
-
Sweden
-
Switzerland
-
Syria
-
Taiwan
-
Tajikistan
-
Tanzania
-
Thailand
-
Trinidad and Tobago
-
Tunisia
-
Turkey
-
UAE
-
Uganda
-
Ukraine
-
United Kingdom
-
United States
-
Uruguay
-
Uzbekistan
-
Venezuela
-
Vietnam
-
Yemen
-
Zambia
-
Zimbabwe
- Forex
- Crypto
Live News
